Resveratrol - A comprehensive review of recent advances in anticancer drug design and development

被引:79
作者
Ahmadi, Reza [1 ,2 ]
Ebrahimzadeh, Mohammad Ali [1 ,2 ]
机构
[1] Mazandaran Univ Med Sci, Sch Pharm, Dept Med Chem, Sari, Iran
[2] Mazandaran Univ Med Sci, Hemoglobinopathy Inst, Pharmaceut Sci Res Ctr, Sari, Iran
关键词
Anticancer; Antitumor; Chemotherapy; Polyphenol; Phytoalexin; Resveratrol; Stilbenoid; HUMAN HEPATOMA-CELLS; IN-VITRO; BIOLOGICAL EVALUATION; CANCER CELLS; CYCLE ARREST; TUMOR-GROWTH; ANALOGS; DERIVATIVES; PROLIFERATION; PTEROSTILBENE;
D O I
10.1016/j.ejmech.2020.112356
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Resveratrol is a natural polyphenolic stilbene isolated from various plants, foods and beverages with a broad spectrum of biological and pharmacological properties through modulating diverse targets and signaling pathways. Particularly, it has attracted a great deal of attention as a promising and multitarget anticancer agent due to its potential use in chemoprevention and chemotherapy of various tumors. However, unfavorable pharmacokinetics/pharmacodynamics profile such as poor bioavailability restricted its applications. Therefore, medicinal chemists have synthesized a lot of novel derivatives and analogues of resveratrol using different modification strategies to overcome these limitations and improve anticancer efficacy. Herein, we reviewed the design, synthesis, structure-activity relationship and mechanism of the most potent and privileged resveratrol-based compounds that showed promising anticancer activities in the last five years. We classified these compounds into the ten different categories based on their chemical structure similarities. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:38
相关论文
共 79 条
[1]  
Aldawsari F.S., 2016, SYNTHESIS THEIR BIOL, DOI [10.7939/R3QR4NZ6S., DOI 10.7939/R3QR4NZ6S]
[2]   Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents [J].
Aldawsari, Fahad S. ;
Aguayo-Ortiz, Rodrigo ;
Kapilashrami, Kanishk ;
Yoo, Jakyung ;
Luo, Minkui ;
Medina-Franco, Jose L. ;
Velazquez-Martinez, Carlos A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (05) :695-703
[3]   Design and synthesis of resveratrol-salicylate hybrid derivatives as CYP1A1 inhibitors [J].
Aldawsari, Fahad S. ;
Elshenawy, Osama H. ;
El Gendy, Mohamed A. M. ;
Aguayo-Ortiz, Rodrigo ;
Baksh, Shairaz ;
El-Kadi, Ayman O. S. ;
Velazquez-Martinez, Carlos A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (06) :884-895
[4]   Imidazole analogues of resveratrol: synthesis and cancer cell growth evaluation [J].
Bellina, Fabio ;
Guazzelli, Nicola ;
Lessi, Marco ;
Manzini, Chiara .
TETRAHEDRON, 2015, 71 (15) :2298-2305
[5]   A novel tetrazole analogue of resveratrol is a potent anticancer agent [J].
Bommagani, Shobanbabu ;
Penthala, Narsimha Reddy ;
Balasubramaniam, Meenakshisundaram ;
Kuravi, Sudhakiranmayi ;
Caldas-Lopes, Eloisi ;
Guzman, Monica L. ;
Balusu, Ramesh ;
Crooks, Peter A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (02) :172-178
[6]   Resveratrol-Related Polymethoxystilbene Glycosides: Synthesis, Antiproliferative Activity, and Glycosidase Inhibition [J].
Cardullo, Nunzio ;
Spatafora, Carmela ;
Musso, Nicolo ;
Barresi, Vincenza ;
Condorelli, Daniele ;
Tringali, Corrado .
JOURNAL OF NATURAL PRODUCTS, 2015, 78 (11) :2675-2683
[7]  
Chan Eric Wei Chiang, 2019, Journal of Applied Pharmaceutical Science, V9, P124, DOI 10.7324/JAPS.2019.90717
[8]  
Chatterjee A., 2015, NOVEL RESVERATROL AN, P4650, DOI [10.1158/1538-7445., DOI 10.1158/1538-7445]
[9]   Antioxidant activities of novel resveratrol analogs in breast cancer [J].
Chatterjee, Anwesha ;
Ronghe, Amruta ;
Padhye, Subhash B. ;
Spade, David A. ;
Bhat, Nimee K. ;
Bhat, Hari K. .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2018, 32 (01)
[10]   A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells [J].
Chelsky, Zachary L. ;
Yue, Peibin ;
Kondratyuk, Tamara P. ;
Paladino, David ;
Pezzuto, John M. ;
Cushman, Mark ;
Turkson, James .
MOLECULAR PHARMACOLOGY, 2015, 88 (03) :524-533